There remains a paucity of literature on musculoskeletal dysfunction, biomechanics, and pathologies of the lower extremity during pregnancy. There are a multitude of physiologic changes that affect a large percentage of patients throughout pregnancy. Podiatric pathologies observed during gestation can be debilitating for this population, ranging from musculoskeletal and biomechanical causes to traumatic injuries and thromboembolic events. This literature review aims to provide an updated review of lower extremity considerations during pregnancy. The authors seek to provide guidance to clinicians based on a review of the available evidence today, and we aim to address deficiencies in research involving the pregnant population.
BiggioJRJr.Research in pregnant subjects: increasingly important, but challenging. Ochsner J. 2020;20(1):39-43.
2.
LyerlyADMitchellLMArmstrongEM, et al. Risk and the pregnant body. Hastings Cent Rep. 2009;39(6):34-42.
3.
KrubinerCBFadenRR. Pregnant women should not be categorised as a “vulnerable population” in biomedical research studies: ending a vicious cycle of “vulnerability.”J Med Ethics. 2017;43(10):664-665.
4.
Committee on Ethics. ACOG committee opinion no. 646: ethical considerations for including women as research participants. Obstet Gynecol. 2015;126(5):e100-e107.
5.
van der ZandeISEvan der GraafROudijkMAvan DeldenJJM. A qualitative study on acceptable levels of risk for pregnant women in clinical research. BMC Med Ethics. 2017;18(1):35. doi:10.1186/s12910-017-0194-9
6.
AnselmoDSLoveETangoDNRobinsonL. Musculoskeletal effects of pregnancy on the lower extremity a literature review. J Am Podiatr Med Assoc. 2017;107(1):60-64. doi:10.7547/15-061
7.
WilliamsonC. Nutrition in pregnancy. Nutrition Bulletin. 2006;31:28-59. doi:10.1111/j.1467-3010.2006.00541.x
8.
BirdARMenzHBHydeCC. The effect of pregnancy on footprint parameters a prospective investigation. J Am Podiatr Med Assoc. 1999;89(8):405-409. doi:10.7547/87507315-89-8-405
9.
LymberyJKGilleardW. The stance phase of walking during late pregnancy: temporospatial and ground reaction force variables. J Am Podiatr Med Assoc. 2005;95:247-253. doi:10.7547/0950247
10.
BrancoMSanto-RochaRAguitarLVieiraFVelosoA. Kinematic analysis of gait in the second and third trimesters of pregnancy. J Pregnancy. 2013;2013:718095. doi:10.1155/2013/718095
11.
AlbinoMASMocclelinASFirmentoBSDriussoP. Modificações da força de propulso da marcha durante a gravidez: efeito das alterações nas dimensões dos pés. Rev Bras Ginecol Obstet. 2011;33(7):164-169.
12.
FotiTDavidsJRBagleyA. A biomechanical analysis of gait during pregnancy. J Bone Joint Surg. 2000;82A(5):625-632. doi:10.2106/00004623-200005000-00003
13.
BlockRAHessLATimpanoEV. Physiologic changes during pregnancy. JAPMA. 1985;75:297. doi:10.5830/CVJA-2016-021
14.
SegalNABoyerERTeran-YenglePGlassNAHillstromHJYackHJ. Pregnancy leads to lasting changes in foot structure. Am J Phys Med Rehabil. 2013;92(3):232-240. doi:10.1097/PHM.0b013e31827443a9
15.
Gijon-NogueronGAGavilan-DiazMValle-FunesVJimenez-CebrianAMCervera-MarinJAMorales-AsencioJM. Anthropometric foot changes during pregnancy: a pilot study. J Am Podiatr Med Assoc. 2013;103(4):314-321. doi:10.7547/1030314
16.
OchalekKPacygaKCuryłoMFrydrych-SzymonikASzygulaZ. Risk factors related to lower limb edema, compression, and physical activity during pregnancy: a retrospective study. Lymphat Res Biol. 2017;15(2):166-171. doi:10.1089/lrb.2016.0038
17.
SwamyGKHeineRPHendrixSL, eds. Lower-Extremity Edema During Late Pregnancy. Content last modified 2018. Merck Manual [database online]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2012. Accessed 2020.
18.
AricaIEBostanciSKocyigitPAricaDA. Clinical and sociodemographic characteristics of patients with ingrown nails. J Am Podiatr Med Assoc. 2019;109(3):201-206. doi:10.7547/17-023
19.
MayeauxEJJrCarterCMurphyTE. Ingrown toenail management. Am Fam Physician. 2019;100(3):158-164.
20.
TangRChenMJDingGD, et al. Associations of prenatal exposure to phenols with birth outcomes. Environ Pollut. 2013;178:115-120. doi:10.1016/j.envpol.2013.03.023
21.
FranklinMConner-KerrT. An analysis of posture and back pain in the first and third trimesters of pregnancy. J Orthop Sports Phys Ther. 1998;28:133-138.
22.
KesikburunSGüzelküçük FidanÜUDemirYErgünATanAK. Musculoskeletal pain and symptoms in pregnancy: a descriptive study. Ther Adv Musculoskelet Dis. 2018;10(12):229-234. doi:10.1177/1759720X18812449
SadlerTW. Establishing the embryonic axes: prime time for teratogenic insults. J Cardiovasc Dev Dis. 2017;4(3):15. doi:10.3390/jcdd4030015
25.
De SantisMCesariENobiliEStrafaceGCavaliereAFCarusoA. Radiation effects on development. Birth Defects Res C Embryo Today. 2007;81(3):177-182. doi:10.1002/bdrc.20099
26.
HaverstockBDChenFJacobsAM. Considerations of prescription medications for the pregnant podiatric patient. J Am Podiatr Med Assoc. 1996;86(7):334-346. doi:10.7547/87507315-86-7-334
27.
StillhartCVučićevićKAugustijnsP, et al. Impact of gastrointestinal physiology on drug absorption in special populations–an UNGAP review. Eur J Pharm Sci. 2020;147:105280. doi:10.1016/j.ejps.2020.105280
28.
CostantineMM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014;5:65. doi:10.3389/fphar.2014.00065
29.
HebertMFEasterlingTRKirbyB, et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther. 2008;84(2):248-253. doi:10.1038/clpt.2008.1
30.
PeruccaECremaA. Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet. 1982;7(4):336-352. doi:10.2165/00003088-198207040-00004
31.
MullerAEMoutonJWOostvogelPM, et al. Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother. 2010;54(5):2175-2181. doi:10.1128/AAC.01017-09
32.
HaasDMQuinneySKClayJM, et al. Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol. 2013;30(4):275-281. doi:10.1055/s-0032-1323590
33.
FeghaliMVenkataramananRCaritisS. Pharmacokinetics of drugs in pregnancy. Semin Perinatol. 2015;39(7):512-519. doi:10.1053/j.semperi.2015.08.003
34.
GriffithsSKCampbellJP. Placental structure, function and drug transfer. Cont Educ Anaesth Crit Care Pain. 2015;15(2):84-89. doi:10.1093/bjaceaccp/mku013
35.
MirkinBL. Drug therapy and the developing human: who cares?Clin Toxicol. 1976;9(1):93-106. doi:10.3109/15563657608995411
36.
LeekhaSTerrellCLEdsonRS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86(2):156-167. doi:10.4065/mcp.2010.0639
37.
ReyesMPOstreaEMJrCabinianAESchmittCRintelmannW. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant?Am J Obstet Gynecol. 1989;161(4):977-981. doi:10.1016/0002-9378(89)90766-7
38.
American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106(2):413-425. doi:10.1097/00006250-200508000-00050
39.
ThinkhamropJHofmeyrGJAdetoroOLumbiganonPOtaE. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane Database Syst Rev. 2015;1:CD002250. doi:10.1002/14651858.CD002250.pub3
40.
BookstaverPBBlandCMGriffinBStoverKREilandLSMcLaughlinM. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052-1062. doi:10.1002/phar.1649
41.
PatilASShengJSDotters-KatzSKSchmollMSOnslowML. Principles of anti-infective dosing in pregnancy. Clin Ther. 2016;38(9):2006-2015. doi:10.1016/j.clinthera.2016.08.005
42.
ElkomyMHSultanPDroverDR. Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery. Antimicrob Agents Chemother. 2014;58:3504-3513. doi:10.4065/mcp.2010.0639
43.
MillerJEWuCPedersenLHde KlerkNOlsenJBurgnerDP. Maternal antibiotic exposure during pregnancy and hospitalization with infection in offspring: a population-based cohort study. Int J Epidemiol. 2018;47(2):561-571. doi:10.1093/ije/dyx272
44.
RitchieJR. Orthopedic considerations during pregnancy. Clin Obstet Gynecol. 2003;46(2):456-466. doi:10.1097/00003081-200306000-00024
45.
WerlerMMYazdyMMKasserJR. Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring. Am J Epidemiol. 2014;180(1):86-93. doi:10.1093/aje/kwu096
46.
DesaiPSukM. Orthopedic trauma in pregnancy. Am J Orthop (Belle Mead NJ). 2007;36(11):E160-E166.
47.
StanhopeTJGillLARoseC. Chronic opioid use during pregnancy: maternal and fetal implications. Clin Perinatol. 2013;40(3):337-350. doi:10.1016/j.clp.2013.05.015
48.
YazdyMMDesaiRJBroglySB. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 2015;4(2):56-70. doi:10.1055/s-0035-1556740
49.
JanssonLMVelezMHarrowC. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009;5(1):47-55.
50.
Cherobin ACFP TavaresGT. Safety of local anesthetics. An Bras Dermatol. 2020;95(1):82-90. doi:10.1016/j.abd.2019.09.025
51.
MyrexPHarperLGouldS. Corticosteroid injection for an orthopedic complaint in a female with gestational diabetes. Sports Med Open. 2018;4(1):3. doi:10.1186/s40798-017-0115-y
52.
KempMWNewnhamJPChallisJGJobeAHStockSJ. The clinical use of corticosteroids in pregnancy. Hum Reprod Update. 2016;22(2):240-259. doi:10.1093/humupd/dmv047
53.
ChenS. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins (Basel). 2012;4(10):913-939. doi:10.3390/toxins4100913
54.
TanMKimEKorenGBozzoP. Botulinum toxin type A in pregnancy. Can Fam Physician. 2013;59(11):1183-1184.
55.
MorganJCIyerSSMoserETSingerCSethiKD. Botulinum toxin A during pregnancy: a survey of treating physicians. J Neurol Neurosurg Psychiatry. 2006;77(1):117-119. doi:10.1136/jnnp.2005.063792
56.
NewmanWJDavisTLPadaliyaBB, et al. Botulinum toxin type A therapy during pregnancy. Mov Disord. 2004;19(11):1384-1385. doi:10.1002/mds.20205
57.
BrentRL. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy. Am J Obstet Gynecol. 2009;200(1):4-24. doi:10.1016/j.ajog.2008.06.032
58.
YoonISlesingerTL. Radiation Exposure in Pregnancy. StatPearls; 2020.
59.
TejwaniNKliftoKLoozeCKliftoCS. Treatment of pregnant patients with orthopaedic trauma. J Am Acad Orthop Surg. 2017;25(5):e90-e101. doi:10.5435/JAAOS-D-16-00289
60.
MatzonJLLutskyKFRicciEKBeredjiklianPK. Considerations in the radiologic evaluation of the pregnant orthopaedic patient. J Am Acad Orthop Surg. 2015;23(8):485-491. doi:10.5435/JAAOS-D-14-00274
Centers for Disease Control and Prevention. Radiation and your health: health effects of radiation: health effects depend on the dose. Date unknown. Accessed April 21, 2023. www.cdc.gov/nceh/radiation/dose.html
63.
ToppenbergKSHillDAMillerDP. Safety of radiographic imaging during pregnancy. Am Fam Physician. 1999;59(7):1813-1818, 1820.
64.
MervakBMAltunEMcGintyKAHyslopWBSemelkaRCBurkeLM. MRI in pregnancy: indications and practical considerations. J Magn Reson Imaging. 2019;49(3):621-631. doi:10.1002/jmri.26317
65.
TurkbeyBRosenkrantzABHaiderMA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340-351. doi:10.1016/j.eururo.2019.02.033
66.
WildeJPRiversAWPriceDL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol. 2005;87:335-353. doi:10.1016/j.pbiomolbio.2004.08.010
67.
AbramowiczJSKossoffGMarsalKTer HaarG. Safety statement, 2000 (reconfirmed 2003). International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Ultrasound Obstet Gynecol. 2003;21:100. doi:10.1002/uog.36
68.
TakalkarAMKhandelwalALokitzSLilienDLStabinMG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med. 2011;52:1035-1040.
69.
BuralGGLaymonCMMountzJM. Nuclear imaging of a pregnant patient: should we perform nuclear medicine procedures during pregnancy?Mol Imaging Radionucl Ther. 2012;21(1):1-5. doi:10.4274/Mirt.123
70.
Pandit-TaskarNDauerLTMontgomeryLSt GermainJZanzonicoPBDivgiCR. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med. 2006;47:1202-1208.
71.
SreetharanSThomeCTharmalingamS, et al. Ionizing radiation exposure during pregnancy: effects on postnatal development and life. Radiat Res. 2017;187:647-658. doi:10.1667/RR14657.1
72.
LemnosJALockwoodCJ, eds. Obstetric and medical complications. In: Guidelines for Perinatal Care. 6th ed.American Academy of Pediatrics, American College of Obstetricians and Gynecologists; 2007:197.
Mendez-FigueroaHDahlkeJDVreesRARouseDJ. Trauma in pregnancy: an updated systematic review. Am J Obstet Gynecol. 2013;209(1):1-10. doi:10.1016/j.ajog.2013.01.021
75.
AmorosaLFAmorosaJHWellmanDSLorichDGHelfetDL. Management of pelvic injuries in pregnancy. Orthop Clin North Am. 2013;44(3):301-315. doi:10.1016/j.ocl.2013.03.005
76.
PetronePMariniCP. Trauma in pregnant patients. Curr Probl Surg. 2015;52(8):330-351. doi:10.1067/j.cpsurg.2015.07.001
77.
LuciaADantoniSE. Trauma management of the pregnant patient. Crit Care Clin. 2016;32(1):109-117. doi:10.1016/j.ccc.2015.08.008
78.
MatthewsLJMcCondaDBLalliTADaffnerSD. Orthostetrics: management of orthopedic conditions in the pregnant patient. Orthopedics. 2015;38(10):e874-e880. doi:10.3928/01477447-20151002-53
MalihaGMorganJVrahasM. Transient osteoporosis of pregnancy. Injury. 2012;43:1237-1241. doi:10.1016/j.injury.2012.03.009
81.
HerathMWongPTrinhA, et al. Minimal-trauma ankle fractures predominate during pregnancy: a 17-year retrospective study. Arch Osteoporos. 2017;12(1):86. doi:10.1007/s11657-017-0380-x
82.
Sanz-SalvadorLGarcia-PerezMATarinJJCanoA. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol. 2015;172(2):R53-R65. doi:10.1530/EJE-14-0424
83.
PatlasNGolombGYaffePPintoTBreuerEOrnoyA. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60:68-73. doi:10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H
84.
CakmakBRibeiroAPInanirA. Postural balance and the risk of falling during pregnancy. J Matern Fetal Neonatal Med. 2016;29(10):1623-1625. doi:10.3109/14767058.2015.1057490
85.
RuffoloDC. Trauma care and managing the injured pregnant patient. J Obstet Gynecol Neonatal Nurs. 2009;38(6):704-714. doi:10.1111/j.1552-6909.2009.01072.x
86.
KuczkowskiKM. Trauma during pregnancy: a situation pregnant with danger. Acta Anaesthesiol Belg. 2005;56(1):13-18.
87.
SchwarzkopfRGrossSCCoopersmithAGidumalR. Ankle fracture surgery on a pregnant patient complicated by intraoperative emergency caesarian section. Case Rep Orthop. 2013;2013:962794. doi:10.1155/2013/962794
88.
JainVChariRMaslovitzS, et al. Guidelines for the management of a pregnant trauma patient. J Obstet Gynaecol Can. 2015;37(6):553-574. doi:10.1016/s1701-2163(15)30232-2
89.
HillKLGrossMESuttonKMMulcaheyMK. Evaluation and resuscitation of the pregnant orthopaedic trauma patient: considerations for maternal and fetal outcomes. JBJS Rev. 2019;7(12):e3. doi:10.2106/JBJS.RVW.19.00013
90.
AhmadMAKuhanendranDKamandeIWCharalambidesC. Accelerated tibial fracture union in the third trimester of pregnancy: a case report. J Med Case Rep. 2008;2:44. doi:10.1186/1752-1947-2-44
91.
GiordanoBDBaumhauerJFMorganTLRechtineGRII. Patient and surgeon radiation exposure: comparison of standard and mini-C arm fluoroscopy. J Bone Joint Surg Am. 2009;91(2):297-304. doi:10.2106/JBJS.H.00407
92.
AllaertSECarlierSPWeyneLPVertommenDJDutréPEDesmetMB.First trimester anesthesia exposure and fetal outcome. A review. Acta Anaesthesiol Belg. 2007;58(2):119-123.
93.
HaraNMiyamotoTYamaguchiJ, et al. Treatment outcomes of anticoagulant therapy and temporary inferior vena cava filter implantation for pregnancy complicated by venous thrombosis. Ann Vasc Dis. 2018;11(1):106-111. doi:10.3400/avd.oa.17-00100
94.
DeitelzweigSB. Management and prevention of venous thromboembolism including surgery and the pregnant state. Ochsner J. 2002;4(1):23-29.
95.
HeitJAKobbervigCEJamesAHPettersonTMBaileyKRMeltonLJIII. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697-706. doi:10.7326/0003-4819-143-10-200511150-00006
96.
HolmesVAWallaceJM. Haemostasis in normal pregnancy: a balancing act?Biochem Soc Trans. 2005;33(pt 2):428-432. doi:10.1042/BST0330428
97.
PompERLenselinkAMRosendaalFRDoggenCJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637. doi:10.1111/j.1538-7836.2008.02921.x
98.
PanăRCPanăLMIstratoaieO, et al. Incidence of pulmonary and/or systemic thromboembolism in pregnancy. Curr Health Sci J. 2016;42(3):283-288. doi:10.12865/CHSJ.42.03.08
99.
JacobsenAFSkjeldestadFESandsetPM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study. Am J Obstet Gynecol. 2008;198(2):233.e1-233.e7. doi:10.1016/j.ajog.2007.08.041
100.
RayJGChanWS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54(4):265-271. doi:10.1097/00006254-199904000-00023
101.
JamesAHTapsonVFGoldhaberSZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193(1):216-219. doi:10.1016/j.ajog.2004.11.037
102.
Blanco-MolinaATrujillo-SantosJCriadoJ, et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost. 2007;97(2):186-190.
De StefanoVMartinelliIRossiE, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006;135(3):386-391. doi:10.1111/j.1365-2141.2006.06317.x
105.
Brill-EdwardsPGinsbergJSGentM, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group. N Engl J Med. 2000;343(20):1439-1444. doi:10.1056/NEJM200011163432002
106.
PabingerIGrafenhoferHKyrlePA, et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002;100(3):1060-1062. doi:10.1182/blood-2002-01-0149
107.
SimioniPTormeneDPrandoniPGirolamiA. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism. Thromb Haemost. 2001;86(3):929.
108.
KahnRLStantonMATong-NgorkSLiguoriGAEdmondsCRLevineDS. One-year experience with day-of-surgery pregnancy testing before elective orthopedic procedures. Anesth Analg. 2008;106(4):1127-1131. doi:10.1213/ane.0b013e31816788df
109.
KahnSRShbakloHLampingDL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105-1112. doi:10.1111/j.1538-7836.2008.03002.x
110.
WikHSJacobsenAFSandvikLSandsetPM. Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. J Thromb Haemost. 2012;10(5):840-847. doi:10.1111/j.1538-7836.2012.04690.x
111.
Sousa GomesMGuimarãesMMontenegroN. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med. 2019;32(14):2418-2428. doi:10.1080/14767058.2018.1434141
112.
YaakobCADzarrAAIsmailAAZuky Nik LahNAHoJJ. Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy. Cochrane Database Syst Rev. 2010;6:CD007801. doi:10.1002/14651858.CD007801.pub2
113.
BatesSMGreerIAMiddeldorpSVeenstraDLPrabulosAMVandvikPO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(suppl 2):e691S-e736S. doi:10.1378/chest.11-2300
114.
BleharMCSpongCGradyCGoldkindSFSahinLClaytonJA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013;23(1):e39-e45. doi:10.1016/j.whi.2012.10.003
